Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

P18IN003 is an inhibitor of p18INK4C.1 It increases the number of cobblestone islands in long-term cultures of isolated mouse bone marrow nucleated cells (BMNCs), indicating an increase in the frequency of primitive hematopoietic cells, in a p18INK4C-dependent manner. P18IN003 (20 nM) sensitizes p16highpRbhigh patient-derived breast cancer cells to the cyclin-dependent kinase 4 (Cdk4) and Cdk6 inhibitor ribociclib (LEE011; Item No. 17666).2 It has been used to promote the expansion of hematopoietic cells in vitro prior to competitive bone marrow transplant in mice.1
WARNING This product is not for human or veterinary use.
1. Small-
2. Author correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer. Nat. Commun. 13(1), 6928 (2022).